Summary of Purpose
To evaluate the efficacy and safety of gavestinel in patients with a clinical diagnosis of acute stroke.Read More →
The following dates are available for this trial. Trial information last updated on 12 August 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Glaxo Wellcome, Research Triangle, NC
Stratified, randomized, international, double-blind, placebo controlled trials of 1367 patients at 132 centers. Patients were stratified by age (75 vs >75 years) and initial stroke severity (National Institutes of Health [NIH] Stroke Scale scores of 2-5, 6-13, or 14).
Ralph L. Sacco, MD, MS, The Neurological Institute, Columbia University, 710 W 168th St, Room 547, New York, NY firstname.lastname@example.org